These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 34015982)

  • 1. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.
    Saeedi-Boroujeni A; Mahmoudian-Sani MR; Nashibi R; Houshmandfar S; Tahmaseby Gandomkari S; Khodadadi A
    Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):247-258. PubMed ID: 34015982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
    Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
    Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
    Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
    Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?
    Saeedi-Boroujeni A; Mahmoudian-Sani MR; Bahadoram M; Alghasi A
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):37-45. PubMed ID: 33099890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
    Paniri A; Akhavan-Niaki H
    Life Sci; 2020 Sep; 257():118114. PubMed ID: 32693241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications?
    Quagliariello V; Bonelli A; Caronna A; Lombari MC; Conforti G; Libutti M; Iaffaioli RV; Berretta M; Botti G; Maurea N
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9169-9171. PubMed ID: 32965010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection].
    Chemarin M; Dufies O; Mazet A; Mellan E; Coudereau R; Py BF; Boyer L; Venet F
    Med Sci (Paris); 2022; 38(6-7):545-552. PubMed ID: 35766852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
    Bertoni A; Penco F; Mollica H; Bocca P; Prigione I; Corcione A; Cangelosi D; Schena F; Del Zotto G; Amaro A; Paladino N; Pontali E; Feasi M; Signa S; Bustaffa M; Caorsi R; Palmeri S; Contini P; De Palma R; Pfeffer U; Uva P; Rubartelli A; Gattorno M; Volpi S
    J Allergy Clin Immunol; 2022 Oct; 150(4):796-805. PubMed ID: 35835255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.
    Huang Y; Jiang H; Chen Y; Wang X; Yang Y; Tao J; Deng X; Liang G; Zhang H; Jiang W; Zhou R
    EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29531021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
    Bahadoram M; Keikhaei B; Saeedi-Boroujeni A; Mahmoudian-Sani MR
    Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):997-1001. PubMed ID: 33416933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
    Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients.
    Gedefaw L; Ullah S; Leung PHM; Cai Y; Yip SP; Huang CL
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19.
    López-Reyes A; Martinez-Armenta C; Espinosa-Velázquez R; Vázquez-Cárdenas P; Cruz-Ramos M; Palacios-Gonzalez B; Gomez-Quiroz LE; Martínez-Nava GA
    Front Immunol; 2020; 11():570251. PubMed ID: 33193349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF; Te Velde AA
    Front Immunol; 2020; 11():1580. PubMed ID: 32670297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
    Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
    J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19].
    Ren Z; Che P; Li Z; Mo M; Zhang S; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):844-850. PubMed ID: 34533131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.